Given its anticipated diverse population
(;40% nonwhites with a wide age
and BMI range) selected without regard
to baseline 25OHD concentration, its
long-term follow-up, and its careful assessment
of safety, D2d is expected
to contribute important insights into
the heterogeneity of treatment effect
and safety profile of vitamin Dsupplementation